Transcription of Clinical Performance Guideline Neonatal Resource Services ...
{{id}} {{{paragraph}}}
Medical Necessity GuidelineClinical Performance Guideline Neonatal Resource Services Neonatal abstinence syndrome (NAS)Purpose: To provide guidelines for the monitoring and management of neonates with intrauterine exposure to illicit substance and for treatment of infants with Neonatal abstinence syndrome (NAS).Target Client Population: This Guideline applies to the neonate who exhibits NAS from intrauterine exposure to illicit drugs or as a result of pain management during NICU hospitalization. BackgroundNeonatal abstinence syndrome has been described as a group of Clinical findings associated with infant opioid withdrawal although signs of withdrawal can be also exhibited in infants exposed in utero to other substances such as benzodiazepines, barbiturates and alcohol. (AAP, 2012) The symptoms of NAS vary based on maternal and Neonatal factors but may include irritability, lethargy, poor feeding, vomiting or diarrhea, hypertonicity, and occasionally seizures.
Medical Necessity Guideline Clinical Performance Guideline Neonatal Resource Services Neonatal Abstinence Syndrome (NAS) Purpose: To provide guidelines for the monitoring and management of neonates with intrauterine exposure to illicit substance and for treatment of infants with neonatal
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Opioid Related Neonatal Abstinence Syndrome, Opioid Related Neonatal Abstinence Syndrome: Is Clonidine, Neonatal abstinence syndrome, Managing, Preventing and Addressing Neonatal Abstinence Syndrome, Managing Abstinence, Impact of Addiction on Infant Mortality, Objectives What is NAS, Neonatal, Syndrome, Abstinence syndrome, PUBLIC HEALTH INTERVENTIONS FOR NEONATAL ABSTINENCE SYNDROME, Modified Finnegan Neonatal Abstinence Score, Neonatal Abstinence Syndrome: Time for